National and subnational mortality effects of major metabolic risk factors and smoking in Iran: a comparative risk assessment Scientific Webinars Farzadfar.

Slides:



Advertisements
Similar presentations
noncommunicable diseases
Advertisements

EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE: An Asian Perspective RODY G. SY, M.D., FPCP, FPCC, FACC Professor, Section of Cardiology Dept of Medicine, UP College.
Project Partners: 計劃夥伴: Funded by: 捐助機構: Gap of Health Care for Midlife Women: Controlling Risk Factors of Stroke as Example Chau Pui Hing CADENZA Project,
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
SUPERSIZED NATION By Jennifer Ericksen August 24, 2007.
UNIVERSITY OF CAMBRIDGE
Cardiovascular Disease: The Number One Killer of Minority Women Statistics, Substrates, Solutions Nanette K. Wenger, M.D., MACP, FACC, FAHA Professor of.
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
The challenge of non-communicable disease in our near neighbours: a disease burden perspective Professor Alan Lopez School of Population Health The University.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 4.
Coronary Heart Disease Prevalence DR. MOHAMMED O. AL-RUKBAN Assistant Professor Department of Family and Community Medicine College of Medicine, King Saud.
H.I. GHOSH1 Challenges of NCDs in Palestine *** Heidar Abu Ghosh Director of Chronic Diseases Program *** Palestinian Medical Relief Society.
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
Non-communicable diseases A global overview David Leon.
E NHANCING C OMPREHENSIVE HIV C ARE : Addressing Cardiovascular Disease (CVD) and other Noncommunicable Diseases (NCDs) Kwasi Torpey MD PhD MPH FGCP Deputy.
Body Weight and Mortality: New Population Based Evidences Body Weight and Mortality: New Population Based Evidences Dongfeng Gu, MD Dongfeng Gu, MD Fu.
Introduction to Public Health January 29,
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
Child deaths: Causes and epidemiological dimensions Robert E. Black, M.D., M.P.H. Johns Hopkins Bloomberg School of Public Health.
Non-communicable diseases David Redfern
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational.
1. Relation between dietary macronutrient and fiber intake with metabolic syndrome in Tehranian adults: Tehran Lipid and Glucose Study Hosseinpour S,
Conclusion In conclusion, preliminary data from this nutrition intervention study suggest that a well balanced Mediterranean-type diet is able to reduce.
Diabetes National Diabetes Control Programme
International Health Policy Program -Thailand Journal Club: Tobacco and Lung Cancer Risk: A Systematic Review and Meta-Analysis Jiraboon Tosanguan.
To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.
Association between Systolic Blood Pressure and Congestive Heart Failure Complication among Hypertensive and Diabetic Hypertensive Patients Mrs. Sutheera.
Dr. Corinne Husten Director (Acting), Office on Smoking and Health The Global Tobacco Epidemic.
Why Stroke Surveillance in the English speaking Caribbean ? Dr. Glennis Andall-Brereton Epidemiologist Caribbean Epidemiology Centre (CAREC/PAHO/WHO)
HDL LowLess than 40 mg/dL High60 mg/dL and above LDL OptimalLess than 100 mg/dL Near Optimal mg/dL Borderline High mg/dL High mg/dL.
Prevalence of Tobacco Use. Current user: A person who has smoked once in the last 30 days Prevalence of tobacco use: The proportion of current users in.
Lesotho STEPS Survey 2012 Fact Sheet John Nkonyana Director Disease Control.
Identifying Persons in Need of Weight-loss Treatment: Evaluation of Potential Treatment Algorithms Caitlin Mason School of Physical and Health Education.
Global and Regional estimates of the Burden Due to Ambient Air Pollution: results from GBD ST AFRICA/MIDDLE-EAST EXPERT MEETING AND WORKSHOP ON THE.
Integrating a gender perspective into environment statistics Workshop on Integrating a Gender Perspective into National Statistics, Kampala, Uganda 4 -
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
By: Dr. AFAF EL- ANSARY Lifestyle and Inheritance.
Health Statistics and Informatics Non-communicable diseases A global overview.
Source: WHO Global Burden of Disease Report Update 2004, Geneva 2008 Global Burden of Disease: chronic NCD responsible for high rates of premature mortality.
Chapter 14 Patterns in Health and Disease: Epidemiology and Physiology EXERCISE PHYSIOLOGY Theory and Application to Fitness and Performance, 6th edition.
The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.
The widespread decline in cardiovascular mortality : A poorly understood triumph David Leon London School of Hygiene & Tropical Medicine Arctic University.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
The short term effects of metabolic syndrome and its components on all-cause-cause mortality-the Taipei Elderly Health Examination Cohort Wen-Liang Liu.
Morocco: Opportunities to Integrate Tobacco Questions for Survey Dr Elkhansa Mahdaoui,MD,MPH Non Communicable Diseases Department Moroccan Ministry of.
Data on lifestyle risk factors in Latvia Dr Iveta Pudule Health Promotion State Agency.
1 Body-Mass Index and Mortality in Korean Men and Women Sun Ha Jee, Ph.D., Jae Woong Sull, Ph.D., Jung yong Park, Ph.D., Sang-Yi Lee, M.D. From the Department.
Cardiovascular Risk: A global perspective
FIGURE 1-2 CARDIOVASCULAR DISEASE DEATHS AS A PERCENTAGE OF ALL DEATHS IN EACH REGION AND TOTAL REGIONAL POPULATION, (DATA FROM MATHERS CD, LOPEZ.
The Global Cardiovascular Risk TransitionClinical Perspective by Goodarz Danaei, Gitanjali M. Singh, Christopher J. Paciorek, John K. Lin, Melanie J. Cowan,
Noncommunicable Diseases Surveillance in Egypt
The smoking epidemic and lung cancer in the EU
World Health Organization
DR GHULAM NABI KAZI WHO Country Office Pakistan
Non-Communicable Diseases Risk Factors Survey in Georgia
Peak oxygen uptake and prevalence of cardiovascular disease risk factors in breast cancer survivors Lahart1, I.M., Metsios1, G.S., Nevill1, A.M., Kitas1,2,
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
Cardiovascular risk factors: are they useful screening tests?
Dr. Ranomal Kotak, Dr. Rozina Mistry and Intisaar Ahmed
Progress and Promise in RAAS Blockade
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei
Prospective Studies Collaboration Lancet 2009; 373:
by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies  Prospective Studies Collaboration  The.
Dr Timothy Armstrong Coordinator
Sex/Gender Differences in the Demography of Aging
Presentation transcript:

National and subnational mortality effects of major metabolic risk factors and smoking in Iran: a comparative risk assessment Scientific Webinars Farzadfar et al PHM 2011 May Presented by Goodarz Danaei

What is the most common cause of death and disabilities in Iran in men? a.Ischemic heart disease b.Stroke c.Lung cancer d.Road traffic injuries

What is the most common cause of death and disabilities in Iran in women? a.Ischemic heart disease b.Stroke c.Lung cancer d.Road traffic injuries

What is the most important NCD risk factor for mortality in Iran? a.Overweight/obesity b.High blood pressure c.Smoking d.High serum cholesterol e.Diabetes and high blood glucose

Outline Background Data sources and methods Findings Conclusion and future directions

Outline Background Data sources and methods Findings Conclusion and future directions

Global epidemiological transition Lopez et al. Lancet 2006

Cardiovascular mortality in high-income countries Vital registration data from WHO MaleFemale

Regional trends in blood pressure North America Male Female Danaei et al. Lancet 2011

Regional trends in blood pressure North America Male Female North Africa and Middle East Danaei et al. Lancet 2011 North Africa and Middle East

Male Female Trends in CVD risk factors in Iran TCBMISBP Farzadfar et al. Lancet 2011, Finucane et al. Lancet 2011, Danaei et al. Lancet 2011

Selected risk factors Systolic blood pressure (SBP) Body mass index (BMI) Fasting plasma glucose (FPG) Total cholesterol (TC) Smoking

Outline Background Data sources and methods Findings Conclusion and future directions

Data sources Risk factor exposure: Non-communicable diseases surveillance survey (2005) Relative risks: Danaei et al 2009 Law 2003 Prospective Studies Collaboration 2007 Mortality: Death registration system (2005) Tehran cemetery

Non-communicable diseases surveillance survey 2005 Multistage systematic cluster sampling 89,400 adults aged years –Questionnaire and physical measurements 50,200 adults aged years –lab data including fasting blood sample

Analytical framework Relative risks Risk factor exposure Optimal exposure level

Population attributable fraction Analytical framework Relative risks Risk factor exposure Optimal exposure level

Population attributable fraction Analytical framework Relative risks Risk factor exposure Optimal exposure level Disease-specific attributable deaths Disease-specific deaths Correction for incompleteness Redistribution of deaths with unspecified cause

Analytical challenges Risk factor exposure: No exposure data in older age groups Disease-specific deaths: Incompleteness of death registration system Redistribution of deaths with unspecified cause Uncertainty in estimates: Sampling uncertainty Etiological effects uncertainty Uncertainty in the model for missing older age groups Completeness estimation uncertainty Uncertainty in proportional redistribution of deaths with unspecified cause

Analytical challenges Risk factor exposure: No exposure data in older age groups Insufficient data on smoking history Disease-specific deaths: Incompleteness of death registration system Redistribution of deaths with unspecified cause Uncertainty in estimates: Sampling uncertainty Etiological effects uncertainty Uncertainty in the model for missing older age groups Completeness estimation uncertainty Uncertainty in proportional redistribution of deaths with unspecified cause

Smoking Impact Ratio The accumulated hazards of smoking depend: the age at which smoking began number of cigarettes smoked per day and cigarette type These data are extremely rare. Estimation of Disease Burden CLC= Age-sex specific lung cancer mortality rate in a population NLC= Age-sex specific lung cancer mortality rate of never-smokers in the same population S*LC and N*LC = Age-sex specific lung cancer mortality rates for smokers and never-smokers in a reference population (Cancer Prevention Study II (CPS- II) )

Analytical challenges Risk factor exposure: No exposure data in older age groups Insufficient data for smoking history Disease-specific deaths: Incompleteness of death registration system Redistribution of deaths with unspecified cause Uncertainty in estimates: Sampling uncertainty Etiological effects uncertainty Uncertainty in the model for missing older age groups Completeness estimation uncertainty Uncertainty in proportional redistribution of deaths with unspecified cause

Analytical challenges Risk factor exposure: No exposure data in older age groups Insufficient data for smoking history Disease-specific deaths: Incompleteness of death registration system Redistribution of deaths with unspecified cause Uncertainty in estimates: Sampling uncertainty Etiological effects uncertainty Uncertainty in the model for missing older age groups Completeness estimation uncertainty Uncertainty in proportional redistribution of deaths with unspecified cause

Selected regions for subnational analysis

Outline Background Data sources and methods Findings Conclusion and future directions

Exposure to selected risk factors in 2005, by region and sex SBP (mmHg) SoutheastNorth-NortheastWestCentralNational

Exposure to selected risk factors in 2005, by region and sex SBP (mmHg) SoutheastNorth-NortheastWestCentralNational SoutheastNorth-NortheastWestCentralNational FPG (mmol/L)

Exposure to selected risk factors in 2005, by region and sex SBP (mmHg) SoutheastNorth-NortheastWestCentralNational BMI (Kg/m^2) SoutheastNorth-NortheastWestCentralNational SoutheastNorth-NortheastWestCentralNational FPG (mmol/L)

Number of deaths attributable to each risk factor in 2005, by sex (in thousands) Risk factorMaleFemale Smoking9 (8.6, 9.4)2 (1.9, 2.1) BMI13 (11, 15)17 (14, 20) TC18 (16, 20)16 (14, 18) FPG17 (14, 20) SBP41 (38, 44)39 (36, 42)

Risk-deleted life expectancy in 2005, by risk factor and region

Risk-deleted life expectancy in 2005, by risk factor and region

Conclusions Few metabolic risk factors account for a substantial loss of life from non-communicable diseases in Iran Non-optimal blood pressure was the most important risk factor and accounted for almost 1 in 6 deaths in adults The selected risk factors did not account for much of the variation in longevity across gender or region.

Future directions Conducting a comprehensive burden of disease study including estimation of role of a wider set of risk factors Evaluating the determinants of exposure to risk factors Designing interventions to reduce exposure to risk factors Conducting experimental studies to evaluate the effectiveness of interventions Implementing interventions and monitoring and evaluation